Two of SA’s most promising female technology entrepreneurs have this year raised millions from astute local and international investors for their global-impact businesses in healthcare and space.
Presagen, co-founded by Dr Michelle Perugini, raised a total of $4.5 million from Jungle Capital group in Australia and US private investor 3Lines Venture Capital, with the SA Government also pitching in.
The funding will help commercialise its Life Whisperer artificial intelligence (AI) platform. Life Whisperer uses AI to identify healthy embryos in in-vitro fertilisation (IVF) with the aim of improving pregnancy outcomes for infertile couples globally.
Every single member of the UN doubled-down today on a commitment to provide universal health coverage to their citizens. The fact that the US will be among them is perhaps evidence of how disconnected these declarations can be from actual domestic political agendas.
Yet the issue is important, and it shows just how out of line the US approach to health care coverage is compared to the rest of the world. Only about half the world’s population has access to the kind of affordable health care services that don’t require crippling out-of-pocket costs. Most of those people are in mid- and low-income countries. Or they are in the wealthiest country on Earth: the US.
Bringing universal health care to everyone is one of the “sustainable development goals,” the ambitious to-do list for UN member countries to complete by 2030. For the UN, universal health care means, “financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all.”
Rejuvenation Biotechnology: on track to be the biggest industry ever.
Dr Aubrey de Grey, CSO at the SENS Research Foundation speaking at Master Investor’s Investing in the Age of Longevity 2019 event. Aubrey discusses Rejuvenation biotechnology and how it’s on track to become the biggest industry ever.
Master Investor is an investment media and events company that delivers independent, financial commentary and analysis to UK private investors and traders through events, magazines, news, blogs, podcasts and daily/weekly newsletters. Read our latest magazine at www.masterinvestor.co.uk/magazine Book a free ticket (use code MIYT) to attend the annual Master Investor Show (28th March 2020): https://masterinvestorshow-2020.reg.buzz Keep in touch: Newsletter | https://masterinvestor.co.uk/subscribe Twitter | https://twitter.com/masterinvestor Facebook | https://facebook.com/masterinvestor LinkedIn | https://www.linkedin.com/company/masterinvestor
Gene therapies to reverse immunosenescence and atherosclerosis.
CEO of Repair Biotechnologies speaking at Master Investor’s Investing in the Age of Longevity 2019 event. Reason discusses gene therapies to reverse immunosenescence and atherosclerosis.
Master Investor is an investment media and events company that delivers independent, financial commentary and analysis to UK private investors and traders through events, magazines, news, blogs, podcasts and daily/weekly newsletters.
Read our latest magazine at www.masterinvestor.co.uk/magazine
Book a free ticket (use code MIYT) to attend the annual Master Investor Show (28th March 2020): https://masterinvestorshow-2020.reg.buzz
The national artificial intelligence strategy, which was unveiled in November, will focus on five key sectors — transport and logistics, smart cities and estates, safety and security, healthcare, and education.
Read the full story: https://www.straitstimes.com/singapore/tapping-ai-to-deliver-municipal-services-detect-issues
Get the latest news updates: http://www.straitstimes.com
Follow The Straits Times online: Twitter: https://www.twitter.com/STcom Facebook: https://www.facebook.com/TheStraitsTimes Instagram: https://www.instagram.com/straits_times/
About The Straits Times: The Straits Times, the English flagship daily of SPH, has been serving readers for more than a century. Launched on July 15, 1845, its comprehensive coverage of world news, East Asian news, Southeast Asian news, home news, sports news, financial news and lifestyle updates makes The Straits Times the most-read newspaper in Singapore.
Hollie Fraser, founder of Books On The Move, worldwide book sharing movement, creative director and ideaXme literature, reading and writing ambassador interviews Matthew Newman, 2019 best Kindle book author.
Matthew S. Newman, is a 39 year old cancer survivor and best-selling author of Starting At The Finish Line. He is a fitness aficionado, and a financial services industry speaker. His mission is help the wider public and to encourage financial preparedness. He does this by telling his story of brain cancer survival and the financial lessons and wisdom he learnt as a result.
Matthew’s book was named a Best Kindle Unlimited Books for 2019. To this day, fitness is still a big part of his life. You can see him here working out shortly after brain surgery! https://www.youtube.com/watch?v=J2G-Sq7iOuM
He is a TedX Talk participant and currently traveling the country giving talks to financial services organizations, such as Transamerica, Primerica, Raymond James and more. https://matthewsnewman.com/speaking
For the text version of this interview please visit www.radioideaxme.com from week commencing 2 December 2019.
Interview credits: Hollie Fraser https://www.booksonthemoveglobal.com/branches.html ideaXme is a global podcast, creator series and mentor programme. Mission: Move the human story forward! ideaXme Ltd.
Germany’s prized industrial robotics and automation sector is expecting a drop in sales this year for the first time since the global financial crisis, an industry body said on Friday.
The Mechanical Engineering Industry Association (VDMA) is expecting sales to fall by five percent to 14.3 billion euros ($15.8 billion) this year.
This would be the first drop since the 32-percent plunge seen in 2009 in the wake of the crisis.
Haven’t heard from Fossel in awhile. This is long but well indexed in the notes.
My mission is to drastically improve your life by helping you break bad habits, build and keep new healthy habits to make you the best version of yourself.
This video me, Brent Nally, interviewing Dr. Michael Fossel about Telocyte and telomerase gene therapy on November 16, 2019.
- Please consider a donation to me: My PayPal https://paypal.me/BrentNally or my Bitcoin Cash (BCH) address: qr9gcfv92pzwfwa5hj9sqk3ptcnr5jss2g78n7w6f2
SHOW NOTES:
0:20 Dr. Michael Fossel intro — Follow Michael on LinkedIn: https://www.linkedin.com/in/michael-fossel-4196255/ ; http://www.michaelfossel.com/ 2:00 Planned January 2020 interview with Michael. 2:25 Buy Michael’s 3 books: 1) Reversing Human Aging 2) Cells Aging & Human Disease 3) The Telomerase Revolution. 4:15 https://telocyte.com/ 5:07 Aging complexities 8:20 Small molecules won’t reverse human aging. 9:01 People are fixed in their incorrect beliefs about aging. 12:50 Sometimes we have to first go backwards to move forwards. My March 26, 2019 interview with Dr. Ed Park at Recharge Biomedical: https://youtube.com/watch?v=xHgfYKsH0uw&list=UUCwpkla04tVxHJUds2J2aqA&index=6 15:55 Economics of radically increasing the human healthspan. 19:01 Leonard Hayflick 21:05 The rate of telomere loss is linked to many organism’s lifespan. 22:30 Lengthening human telomeres in aging cells “resets” the cells to make them biologically younger. 24:10 Cells, Aging, and Human Disease preface. 28:20 human population if we radically increase human healthspan/lifespan. 31:20 biological vs chronological aging 32:25 telomerase activation is the best point of clinical and financial intervention to cure and prevent age related diseases. 37:30 Data generally doesn’t support the idea that making telomerase more active in humans can cause cancer. Michael beliefs this idea has been propagated by misinterpreting data. 45:02 Causation & Pathology in Alzheimer’s Disease. 46:30 standard cell aging process 49:53 What can you do to help cure human aging? understand the concepts, share this info & invest. 53:40 the FDA is excited about Telocyte’s model. 55:30 Phase 1 human FDA trial costs about $10 million but costs should drop after that. 57:50 It costs Telocyte about $4 million to initially produce the telomerase gene therapy they need to treat their first 12 patients. 58:55 Lets “elephant hunt” to find billionaire investors for Telocyte. 1:01:18 Michael discusses BioViva/Integrated Health Systems & Liz Parrish. My July 10, 2019 interview with BioViva CEO Liz Parrish: https://youtube.com/watch?v=oBFTwGPaPr4 1:02:10 My May 30, 2019 interview with Sierra Sciences CEO Dr. Bill Andrews: https://youtube.com/watch?v=Tx9yG6iTROQ 1:09:45 ethics and risks of telomerase gene therapy. 1:11:15 Unnatural selection on Netflix 1:14:30 Is reality a simulation? 1:18:10 The mind is like a parachute. It only works if it’s open. Data trumps everything always. 1:19:50 telomerase activator pills 1:24:30 Dr. Greg Fahy 1:28:40 https://lifelength.com/ & https://teloyears.com/home/ 1:32:40 My July 17, 2019 interview with Dr. Aubrey de Grey https://www.youtube.com/watch?v=TquJyz7tGfk 1:38:34 Dr. Michael West 1:41:10 Inject snake venom for anti-aging? https://www.youtube.com/watch?v=8q_m-rDUNw0 1:45:15 Bill Haast https://en.wikipedia.org/wiki/Bill_Haast 1:45:50 My October 6, 2019 interview of Dr. Duncan Ross about Kimera exosomes: https://www.youtube.com/watch?v=X8eIxo3eqvQ&t=3s 1:46:15 Brent’s stem cell’s treatment and recovery playlist https://www.youtube.com/playlist?list=PLGjySL94COVQzsAauqp6lZHHzmzBQSmhH 1:51:52 Dr. Maria Blasco 1:52:45 Michael almost got $1 billion for a non-profit translational research for telomerase gene therapy from a wealthy couple in California in 1999. 1:55:45 Dr. Elizabeth Blackburn 1:57:57 Dr. Elissa Epel 2:00:09 Dr. Calvin Harley 2:02:20 Radical honesty and compassion 2:06:25 I recommend the book: Sapiens by Dr. Yuval Noah Harari 2:11:15 Michael’s fascinating experiences. 2:26:30 telomerase gene therapy economies of scale. 2:35:10 Dr. Peter Attia 2:36:50 Peter Rayson, CEO Telocyte. Curing human aging is a systems approach. 2:39:43 Forever Labs 1 year free cryogenic storage discount code ($250 value): BN801 https://foreverlabs.com 2:42:10 Dave Asprey — lack of funding for Telocyte is holding back the potential cure for Alzheimer’s. 2:44:30 Chan Zuckerberg Initiative 2:49:08 health advice 2:56:38 Viome for microbiome 3:01:04 the best current way to measure someone’s age is guessing based off how they look and behave. 3:04:51 transhumanism and ignosticism 3:08:23 Stay curious to continue learning. 3:16:28 “What important truth do very few people agree with you on?” 3:23:30 be considerate
“Demonstrate That Top Financial and Tech Corporations Are Committed to Longevity”
This week two Landmark International Longevity Summits in London attracted the attention of scientists, government officials, major financial corporations, insurance companies, investment banks, and technology companies from around the world. The Landmark AI for Longevity Summit and the First International Longevity Policy and Governance Summit at King’s College London are expected to become the world-leading forums for the Longevity Industry.
